Boston Scientific Receives FDA Clearance for Its Embold Fibered Detachable Coil

Boston Scientific has received the FDA’s 510(k) clearance for its Embold fibered detachable coil, which is used to obstruct or reduce the rate of blood flow in the peripheral vasculature.

The latest in the company’s line of interventional oncology products, the Embold coil is designed to stop hemorrhaging, prevent aneurysm ruptures, reduce the size of certain tumors and treat a variety of venous abnormalities.

The first procedure using the device was performed in late April at the University of Alabama at Birmingham.

Boston Scientific plans a full commercial launch of the device in the U.S. in the coming weeks.